Sort
30,917 grants matching “tumor microenvironment”
Exosome secretion in breast cancer progression
$467,195Alissa M Weaver · Vanderbilt University · R01 · FY2016 · CA
Biology of AR+ prostate cancer metastases and the role of the microenvironment
$467,174Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Quantitative histopathology for cancer prognosis using quantitative phase imaging on stained tissues
$467,172Mark A Anastasio · University Of Illinois At Urbana-Champaign · R01 · FY2023 · CA
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment
$467,151William M Grady · Fred Hutchinson Cancer Center · U54 · FY2024 · CA
Targeting the EGFR-PI3K/mTOR Signaling Circuitry: A Network-Based Approach for Oral Cancer Precision Therapy
$467,098J. Silvio Gutkind · University Of California, San Diego · R01 · FY2021 · DE
Therapeutic targeting of glutamine metabolism in MDS
$467,092Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Role of Tumor Stem Cells Recurrent Prostate Cancer
$467,053Gary Smith · Univ Of North Carolina Chapel Hill · P01 · FY2011 · CA
Role of breast cancer secreted miRNA in brain metastasis
$467,050Shizhen Emily Wang · University Of California, San Diego · R01 · FY2025 · CA
Differences in Tumor Biology of Multiple Myeloma in Association with African Ancestry
$467,019Linda B Baughn · Mayo Clinic Rochester · R37 · FY2024 · CA
Chemical Probes for In Vivo Fibrin Imaging
$466,961Zhaoda Zhang · Massachusetts General Hospital · R01 · FY2015 · CA
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
$466,898Xinna Zhang · Indiana University Indianapolis · R01 · FY2023 · CA
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
$466,898Xinna Zhang · Indiana University Indianapolis · R01 · FY2025 · CA
Novel IL-12 Gene Delivery Vehicles for Transformation of Solid Tumors
$466,837Seth M Pollack · Northwestern University At Chicago · R01 · FY2024 · CA
Tumor-Targeted Multimodality Nanoscale Coordination Polymers for Chemo-Immunotherapy of Metastatic Colorectal Cancer
$466,819Wenbin Lin · University Of Chicago · R01 · FY2023 · CA
Tumor-Targeted Multimodality Nanoscale Coordination Polymers for Chemo-Immunotherapy of Metastatic Colorectal Cancer
$466,819Ralph R Weichselbaum · University Of Chicago · R01 · FY2025 · CA
Znf740 in the regulation of CD8+T cell exhaustion
$466,803Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2023 · CA
Developmental studies to inform clinical stratification and targeting of SHH MB
$466,787Alexandra L. Joyner · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma
$466,752Reuben J Shaw · Salk Institute For Biological Studies · P01 · FY2023 · CA
Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma
$466,751Reuben J Shaw · Salk Institute For Biological Studies · P01 · FY2025 · CA
Gene Edited and Engineered Tumor Cell Therapeutics for Cancer
$466,689Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2021 · NS
Neoadjuvant immunotherapy approaches to early stage melanoma
$466,650Meenhard Herlyn · Wistar Institute · P50 · FY2021 · CA
Functional Cooperation of Tissue Factor and Integrins
$466,643Wolfram Ruf · Scripps Research Institute, The · R01 · FY2015 · HL
Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
$466,587Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
$466,517Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
$466,514Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA